Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Leukemia 19 Leukemia, Myeloid, Chronic-Phase 15 Carcinoma, Renal Cell 15 Kidney Neoplasms 13 Multiple Myeloma 12 Melanoma 11 Neoplasms, Plasma Cell 10 Lymphoma 10 Pancreatic Neoplasms 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Lymphoma, Follicular 7 Waldenstrom Macroglobulinemia 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Burkitt Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell, Marginal Zone 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Immunoglobulin Light-chain Amyloidosis 3 Carcinoma, Non-Small-Cell Lung 3 Blast Crisis 3

Interventions

lutetium Lu 177 dotatate 15 Everolimus 11 Nivolumab 10 pembrolizumab 9 Temozolomide 9 Capecitabine 7 cabozantinib 6 Sunitinib 6 lenvatinib 5 lanreotide 4 gallium Ga 68 dotatate 4 Ipilimumab 4 Etoposide 4 Carboplatin 4 177Lu-octreotide, DOTA(0)-Tyr(3)- 4 telotristat ethyl 3 pazopanib 3 avelumab 3 Octreotide 3 Magnetic Resonance Spectroscopy 3 Injections 3 Cyclophosphamide 3 Cisplatin 3 Bevacizumab 3 surufatinib 2 sintilimab 2 fosbretabulin 2 fludarabine 2 Specimen Handling 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroendocrine Tumors × Interferon-alpha × Clear all

NCT02838342 2021-08-02

EPICentro

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡